Technology
Health
Pharmaceutical

Bayer

$19.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (0.47%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Bayer and other stocks, options, ETFs, and crypto commission-free!

About

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. Read More The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany. BAYRY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
99,762
Headquarters
Leverkusen, Nordrhein-Westfalen
Founded
1952
Market Cap
71.25B
Price-Earnings Ratio
29.46
Dividend Yield
1.82
Average Volume
786.10K
High Today
$19.30
Low Today
$19.15
Open Price
$19.20
Volume
263.23K
52 Week High
$32.80
52 Week Low
$16.58

Collections

Technology
Health
Pharmaceutical
Healthcare
Materials
Advertising and Marketing
Therapy
Business Services

News

Yahoo Finance12h

What Makes Bayer (BAYRY) a New Strong Buy Stock

Bayer (BAYRY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects.

170
ReutersMar 15

Bayer to face couple's Roundup cancer claims in joint trial

A husband and wife who both claim Bayer AG’s glyphosate-based weed killer Roundup caused them to develop cancer will have their cases tried together, a California judge reaffirmed on Thursday, saying jurors will be able to adequately consider the couple’s different exposure levels.

106
Seeking AlphaMar 15

Suitors lining up for Bayer's animal health unit - Bloomberg

Bayer (OTCPK:BAYRY +0.7% ) is moving forward with plans to sell its animal health business, drawing interest from private equity firms like KKR and CVC Capital Partners.

42
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.